Department Of Rheumatology
Elana Bernstein, MD
Dr. Bernstein's clinical and research interests focus on systemic sclerosis (scleroderma), as well as on the treatment of interstitial lung disease and pulmonary hypertension in patients with autoimmune diseases. Dr. Bernstein has a special interest in the management of autoimmune diseases during pregnancy. She is an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons and an Assistant Attending at NewYork-Presbyterian Hospital. Dr. Bernstein is the Program Director of the CUMC/NYP Scleroderma Program.

Dr. Bernstein graduated summa cum laude from Amherst College, and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She was the recipient of the American College of Rheumatology Distinguished Fellow Award and the Charles L. Christian Award for Excellence in Musculoskeletal Research while a rheumatology fellow at Hospital for Special Surgery. Dr. Bernstein has received grants from the National Institutes of Health, Arthritis Foundation, and Rheumatology Research Foundation to study lung disease in scleroderma. Her ongoing research projects focus on interstitial lung disease in scleroderma and on lung transplantation in patients with autoimmune diseases.

Clinical Studies Managed By This Investigator:
Condition Study Title
Autoimmune Disorders [ CLOSED ] Double-blind trial to Test Efficacy of Rituxan (Rituximab) on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Autoimmune Disorders [ CLOSED ] A Study Evaluating Abatacept (Orencia) for Treatment of Systemic Sclerosis
Autoimmune Disorders [ CLOSED ] A study for patients with systemic sclerosis using study drug abituzumab
Pulmonary Hypertension [ CLOSED ] Rituximab for Systemic Sclerosis Associated Pulmonary Arterial Hypertension (SSc-PAH)
Autoimmune Disorders Genome Research in African American Scleroderma Patients (GRASP Study)
Autoimmune Disorders [ CLOSED ] Abituzumab for patients with SSc-ILD taking mycophenolate
Autoimmune Disorders CONQUER Registry to Track Disease Progression in Systemic Sclerosis (Scleroderma)
Autoimmune Disorders [ CLOSED ] AURORA Study: Iloprost for Subjects with Systemic Sclerosis (SSc-Raynaud's Phenomenon)